Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (21-30 of 272) with videos related to

Pageof 28
Sort By:
Seminars in Nephrology|January 29, 2008
Secondary IgA nephropathyShideh Pouria, Jonathan Barratt
Clinical Kidney Journal|December 15, 2025
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizonLydia Roberts, Jonathan Barratt
Kidney International|March 22, 2024
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?Haresh Selvaskandan, Jonathan Barratt
Kidney International|August 1, 2015
Gluten and IgA nephropathy: you are what you eat?Chee Kay Cheung, Jonathan Barratt
Kidney International|June 16, 2011
Inherited IgA glycosylation pattern in IgA nephropathy and HSP nephritis: where do we go next?Joanna K Boyd, Jonathan Barratt
Kidney International|April 21, 2023
The authors replyJonathan Barratt, Brad H Rovin,
Kidney International|April 21, 2023
The authors replyJonathan Barratt, Brad H Rovin,
Kidney International|October 1, 2020
Should we STOP immunosuppression for IgA nephropathy? Long-term outcomes from the STOP-IgAN trialChee Kay Cheung, Jonathan Barratt
Seminars in Nephrology|March 8, 2025
The Rapidly Changing Treatment Landscape of IgA NephropathyChee Kay Cheung, Jonathan Barratt
Journal of the American Society of Nephrology : JASN|April 8, 2022
Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA NephropathyChee Kay Cheung, Jonathan Barratt
Pageof 28

Showing results (21-30 of 272) with videos related to

Sort By:
Pageof 28
Seminars in Nephrology|January 29, 2008
Secondary IgA nephropathyShideh Pouria, Jonathan Barratt
Clinical Kidney Journal|December 15, 2025
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizonLydia Roberts, Jonathan Barratt
Kidney International|March 22, 2024
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?Haresh Selvaskandan, Jonathan Barratt
Kidney International|August 1, 2015
Gluten and IgA nephropathy: you are what you eat?Chee Kay Cheung, Jonathan Barratt
Kidney International|June 16, 2011
Inherited IgA glycosylation pattern in IgA nephropathy and HSP nephritis: where do we go next?Joanna K Boyd, Jonathan Barratt
Kidney International|April 21, 2023
The authors replyJonathan Barratt, Brad H Rovin,
Kidney International|April 21, 2023
The authors replyJonathan Barratt, Brad H Rovin,
Kidney International|October 1, 2020
Should we STOP immunosuppression for IgA nephropathy? Long-term outcomes from the STOP-IgAN trialChee Kay Cheung, Jonathan Barratt
Seminars in Nephrology|March 8, 2025
The Rapidly Changing Treatment Landscape of IgA NephropathyChee Kay Cheung, Jonathan Barratt
Journal of the American Society of Nephrology : JASN|April 8, 2022
Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA NephropathyChee Kay Cheung, Jonathan Barratt
Pageof 28